Type 1 diabetes mellitus in 2011: Heterogeneity of T1DM raises questions for therapy - PubMed (original) (raw)

Review

. 2011 Dec 20;8(2):78-80.

doi: 10.1038/nrendo.2011.228.

Affiliations

Review

Type 1 diabetes mellitus in 2011: Heterogeneity of T1DM raises questions for therapy

Paolo Pozzilli. Nat Rev Endocrinol. 2011.

Abstract

Research in 2011 regarding β-cell destruction, early immunointervention trials and development of late complications in type 1 diabetes mellitus have highlighted the heterogeneity of this disease. Patient phenotyping should be performed for the implementation of tailored therapies, especially taking into account the age at which the disease is diagnosed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Diabetes. 2011 Nov;60(11):3067-72 - PubMed
    1. PLoS One. 2011;6(11):e26873 - PubMed
    1. Diabetes. 2011 Aug;60(8):2144-51 - PubMed
    1. Lancet. 2011 Jul 9;378(9786):140-6 - PubMed
    1. Diabetes. 2004 Oct;53(10):2559-68 - PubMed

Publication types

MeSH terms

LinkOut - more resources